The global human insulin market size was USD 18.17 Billion in 2022 and is expected to register a rapid revenue CAGR of 1.9% during the forecast period. Rapid growth of healthcare industries, rising prevalence of chronic diseases and diabetes, and increasing Research & Development (R&D) activities and government investments are key factors driving market revenue growth. The report covers...